11 citations as recorded by crossref.

1. Orthopedic Implants: Necessity of Coating, Their Advantages, and Challenges J. Pandey & S. Rajput 10.1007/s40735-025-00968-z
2. Direct Hospital Costs per Case of Periprosthetic Hip and Knee Joint Infections in Europe — A Systematic Review D. Szymski et al. 10.1016/j.arth.2024.01.032
3. Economic advantage of ‘self-made’ antibiotic-loaded spacer compared to prefabricated antibiotic-loaded spacer and spacer molds in two-staged revision arthroplasty K. Moerenhout et al. 10.52628/87.3.24
4. Asymptomatic Periprosthetic Joint Infection of the Hip with High-Virulence Pathogens: Report of Two Cases R. Mazzucchelli et al. 10.1155/2022/2699779
5. DRGKB: A Knowledge Base and Platform for Comparison, Evaluation and Worldwide Practices of Diagnosis-Related-Groups S. Ren & B. Shen 10.2139/ssrn.4190877
6. The health-economic burden of hip and knee periprosthetic joint infections in Europe V. Alt et al. 10.1302/2633-1462.63.BJO-2024-0225.R1
7. Vergleich der DRG-Erlöse zwischen Fast- und Slow-Track-Verfahren beim zweizeitigen Prothesenwechsel bei periprothetischen Hüftinfektionen im aG-DRG-System 2020 K. Hierl et al. 10.1007/s00132-021-04106-8
8. Local antibiotic treatment with calcium sulfate as carrier material improves the outcome of debridement, antibiotics, and implant retention procedures for periprosthetic joint infections after hip arthroplasty – a retrospective study K. Reinisch et al. 10.5194/jbji-7-11-2022
9. DRGKB: a knowledgebase of worldwide diagnosis-related groups’ practices for comparison, evaluation and knowledge-guided application S. Ren et al. 10.1093/database/baae046
10. Prosthetic-joint Infections: Mortality Over The Last 10 Years A. Fischbacher & O. Borens 10.7150/jbji.35428
11. Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS) I. Sigmund et al. 10.5194/jbji-10-101-2025